BE1003021A3 - Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. - Google Patents

Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. Download PDF

Info

Publication number
BE1003021A3
BE1003021A3 BE8900321A BE8900321A BE1003021A3 BE 1003021 A3 BE1003021 A3 BE 1003021A3 BE 8900321 A BE8900321 A BE 8900321A BE 8900321 A BE8900321 A BE 8900321A BE 1003021 A3 BE1003021 A3 BE 1003021A3
Authority
BE
Belgium
Prior art keywords
cardiac
preparing
pharmaceutical compositions
cardiovascular system
same
Prior art date
Application number
BE8900321A
Other languages
English (en)
French (fr)
Inventor
Nagy Peter Literati
Hegedus Erzsebet Radvany
Maria Boros
Jeno Szilbereky
Gyoergy Blasko
Bela Gachalyi
Nemes Gizella Hamar
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Application granted granted Critical
Publication of BE1003021A3 publication Critical patent/BE1003021A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
BE8900321A 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer. BE1003021A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881484A HU210122B (en) 1988-03-23 1988-03-23 Process for production of composition against thromboembolytic conditions of circulating system and heart

Publications (1)

Publication Number Publication Date
BE1003021A3 true BE1003021A3 (fr) 1991-10-29

Family

ID=10954680

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900321A BE1003021A3 (fr) 1988-03-23 1989-03-23 Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer.

Country Status (15)

Country Link
JP (1) JPH0222228A (fi)
KR (1) KR890014104A (fi)
BE (1) BE1003021A3 (fi)
CA (1) CA1319607C (fi)
CH (1) CH677732A5 (fi)
DE (1) DE3909707A1 (fi)
ES (1) ES2014060A6 (fi)
FI (1) FI891438A (fi)
FR (1) FR2628972B1 (fi)
GB (1) GB2216421A (fi)
HU (1) HU210122B (fi)
IT (1) IT1229205B (fi)
LU (1) LU87488A1 (fi)
NL (1) NL8900742A (fi)
SE (1) SE8901041L (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3114198B2 (ja) * 1990-11-06 2000-12-04 ソニー株式会社 電子機器
KR19990015198A (ko) * 1997-08-02 1999-03-05 손남율 식물성 항생제
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
CN1665496B (zh) * 2002-05-03 2010-05-05 派普生物保健品公司 Epa和dha在制备二级预防神经性疾患的药物中的用途
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
FR2863170A1 (fr) * 2003-12-08 2005-06-10 Nicolai Christian Paul Xavier Composition regeneratrice et regulatrice de l'appareil digestif
AU2005270825B2 (en) * 2004-08-09 2011-07-07 Enzymotec Ltd. Food products for diabetics
CN101039585B (zh) 2004-08-10 2012-03-14 酶学技术有限公司 用于治疗医学疾病的植物甾醇酯和1,3-甘油二酯的混合物
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
ITMI20052483A1 (it) * 2005-12-23 2007-06-24 Novamont Spa Esche biodegradabili
FR2935393B1 (fr) 2008-08-29 2012-08-24 Tetrahedron Bacteries et levures enrichies en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie
FR2935394B1 (fr) 2008-08-29 2013-03-08 Eco Solution Microorganismes photosynthetiques enrichis en selenium organique a partir de composes seleno-hydroxyacides et leurs applications en nutrition, cosmetique et pharmacie

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612399A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2148713A (en) * 1983-10-24 1985-06-05 Century Lab Inc Pharmaceutical composition and food product comprising higher fatty acids
FR2612399A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation
FR2612373A1 (fr) * 1987-03-18 1988-09-23 Caola Kozmetikai Compositions dietetiques et procede pour leur preparation
GB2216418A (en) * 1988-03-09 1989-10-11 Biorex Kft Antiviral and immunostimulating compositions comprising amino acids and polyunsaturated higher fatty acids.

Also Published As

Publication number Publication date
DE3909707A1 (de) 1989-10-05
CH677732A5 (fi) 1991-06-28
HU210122B (en) 1995-02-28
GB8906856D0 (en) 1989-05-10
FI891438A0 (fi) 1989-03-23
CA1319607C (en) 1993-06-29
JPH0222228A (ja) 1990-01-25
KR890014104A (ko) 1989-10-21
GB2216421A (en) 1989-10-11
SE8901041D0 (sv) 1989-03-23
IT8919876A0 (it) 1989-03-23
FR2628972A1 (fr) 1989-09-29
HUT60436A (en) 1992-09-28
FR2628972B1 (fr) 1994-09-23
ES2014060A6 (es) 1990-06-16
NL8900742A (nl) 1989-10-16
SE8901041L (sv) 1989-09-24
LU87488A1 (fr) 1990-10-02
IT1229205B (it) 1991-07-25
FI891438A (fi) 1989-09-24

Similar Documents

Publication Publication Date Title
BE1003021A3 (fr) Compositions pharmaceutiques agissant en particulier sur le systeme cardiaque et cardiovasculaire et procede pour les preparer.
HK1002633A1 (en) Arysulfonamido-substituted hydroxamix acids
ATA237894A (de) Hochkonzentriertes immunglobulin-präparat und verfahren zu seiner herstellung
FR2440371A1 (fr) Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
BE1002428A3 (fr) Compositions pharmaceutiques agissant sur le coeur et le systeme cardiovasculaire et procede pour leur preparation.
FR2714059B1 (fr) Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2398112A1 (fr) Procede en vue d'ameliorer l'arome et/ou la mousse du vin mousseux, du vin champagnise ou du vin petillant et produits ainsi ameliores
BE1002429A3 (fr) Compositions dietetiques et procede pour leur preparation.
FR2392068A1 (fr) Procede de production d'une charge particulaire enrobee pour polymeres organiques
IS1604B (is) Aðferð til framleiðslu nýrra efnasambanda "LEUSTRODUCINS" úr Streptomyces platensis SANK 60191
BE901433A (fr) Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer.
FR2612526B1 (fr) Procede de preparation d'un additif suralcanise renfermant un derive du bore, l'additif ainsi obtenue et compositions lubrifiantes renfermant ledit additif
Tsai et al. Studies on the stereospecificity of mitochondrial oxidation of phytanic acid and of α-hydroxyphytanic acid
BE893492A (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters
FR2388820A1 (fr) Procede de preparation de composes du silicium presentant des groupes oximes lies au silicium par l'oxygene
FR2456474A1 (fr) Agent d'entretien pouvant etre pulverise a partir d'un conteneur, et procede pour l'entretien d'instruments medicaux, notamment de dentisterie avec un tel agent
FR2378054A1 (fr) Procede de preparation de polyurethanes
BE1001522A3 (fr) Compositions cosmetiques regenerant la peau et leur procede de preparation.
FR2642423B1 (fr) Procede de preparation d'alkyldiethanolamides gras purifies, les produits obtenus et leurs utilisations
KR950014314A (ko) 하이드록실화되거나 산화된 지질 측쇄를 갖는 모에노마이신 분해 생성물 및 모에노마이신 동족체, 이들 화합물의 제조 방법 및 용도
DE69313634D1 (de) Elastosole sowie deren herstellung, verwendung und produkte
DE59309188D1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
AU4347389A (en) Novel s-timolol derivative and process for its preparation
FR2372137A1 (fr) Procede de transformation microbiologique de steroides en 3aa- h-4a-(acide 3'-propionique)-7ab-methylhexahydro-1,5-indanedione
FR2422403A1 (fr) Compositions therapeutiques diuretiques a effet rapide, a base d'acide 4-chloro-n-furfuryl-5-sulfamoylanthranilique et de composes de pteridine

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BIOREX KFT

Effective date: 19960331